Condensed Consolidated Statements of Change in Shareholders’ Equity (Deficit) - USD ($) |
Ordinary Share (Restated) |
Additional paid-in Capital (Restated) |
Accumulated Deficit (Restated) |
Accumulated other comprehensive income (loss) |
Total |
|||
---|---|---|---|---|---|---|---|---|
Balance at Sep. 30, 2023 | $ 13,775 | [1] | $ 587,499 | $ (7,983,590) | $ 54,003 | $ (7,328,313) | ||
Balance (in Shares) at Sep. 30, 2023 | [1] | 2,295,833 | ||||||
Net loss | [1] | (405,129) | (405,129) | |||||
Foreign currency translation | [1] | (164,851) | (164,851) | |||||
Balance at Dec. 31, 2023 | $ 13,775 | [1] | 587,499 | (8,388,719) | (110,848) | (7,898,293) | ||
Balance (in Shares) at Dec. 31, 2023 | [1] | 2,295,833 | ||||||
Balance at Sep. 30, 2023 | $ 13,775 | [1] | 587,499 | (7,983,590) | 54,003 | (7,328,313) | ||
Balance (in Shares) at Sep. 30, 2023 | [1] | 2,295,833 | ||||||
Net loss | (16,692,807) | |||||||
Foreign currency translation | (194,321) | |||||||
Balance at Jun. 30, 2024 | $ 14,674 | [1] | 9,353,861 | (24,676,397) | (140,318) | (15,448,180) | ||
Balance (in Shares) at Jun. 30, 2024 | [1] | 2,445,647 | ||||||
Balance at Dec. 31, 2023 | $ 13,775 | [1] | 587,499 | (8,388,719) | (110,848) | (7,898,293) | ||
Balance (in Shares) at Dec. 31, 2023 | [1] | 2,295,833 | ||||||
Issuance of ordinary shares upon completion of reverse recapitalization | $ 669 | [1] | (1,933,408) | (1,932,739) | ||||
Issuance of ordinary shares upon completion of reverse recapitalization (in Shares) | [1] | 111,480 | ||||||
Issuance of ordinary shares for PIPE investment | $ 25 | [1] | 2,499,975 | 2,500,000 | ||||
Issuance of ordinary shares for PIPE investment (in Shares) | [1] | 4,167 | ||||||
Loan payment converted to shares | $ 205 | [1] | 8,199,795 | 8,200,000 | ||||
Loan payment converted to shares (in Shares) | [1] | 34,167 | ||||||
Net loss | [1] | (14,269,147) | (14,269,147) | |||||
Foreign currency translation | [1] | (9,118) | (9,118) | |||||
Balance at Mar. 31, 2024 | $ 14,674 | [1] | 9,353,861 | (22,657,866) | (119,966) | (13,409,297) | ||
Balance (in Shares) at Mar. 31, 2024 | [1] | 2,445,647 | ||||||
Net loss | [1] | (2,018,531) | (2,018,531) | |||||
Foreign currency translation | [1] | (20,352) | (20,352) | |||||
Balance at Jun. 30, 2024 | $ 14,674 | [1] | 9,353,861 | (24,676,397) | (140,318) | (15,448,180) | ||
Balance (in Shares) at Jun. 30, 2024 | [1] | 2,445,647 | ||||||
Balance at Sep. 30, 2024 | $ 14,674 | [1] | 7,812,836 | (25,798,897) | (287,337) | (18,258,724) | ||
Balance (in Shares) at Sep. 30, 2024 | [1] | 2,445,647 | ||||||
Sales of ordinary shares | $ 65 | [1] | 989,762 | 989,827 | ||||
Sales of ordinary shares (in Shares) | [1] | 10,885 | ||||||
Net loss | [1] | (689,155) | (689,155) | |||||
Foreign currency translation | [1] | 226,818 | 226,818 | |||||
Balance at Dec. 31, 2024 | $ 14,739 | [1] | 8,802,598 | (26,488,052) | (60,519) | (17,731,234) | ||
Balance (in Shares) at Dec. 31, 2024 | [1] | 2,456,532 | ||||||
Balance at Sep. 30, 2024 | $ 14,674 | [1] | 7,812,836 | (25,798,897) | (287,337) | (18,258,724) | ||
Balance (in Shares) at Sep. 30, 2024 | [1] | 2,445,647 | ||||||
Net loss | (22,768,135) | |||||||
Foreign currency translation | 52,674 | |||||||
Balance at Jun. 30, 2025 | $ 14,804 | [1] | 29,743,558 | (48,567,032) | (234,663) | (19,043,333) | ||
Balance (in Shares) at Jun. 30, 2025 | [1] | 2,467,337 | ||||||
Balance at Dec. 31, 2024 | $ 14,739 | [1] | 8,802,598 | (26,488,052) | (60,519) | (17,731,234) | ||
Balance (in Shares) at Dec. 31, 2024 | [1] | 2,456,532 | ||||||
Net loss | [1] | (577,023) | (577,023) | |||||
Foreign currency translation | [1] | (26,182) | (26,182) | |||||
Balance at Mar. 31, 2025 | $ 14,739 | [1] | 8,802,598 | (27,065,075) | (86,701) | (18,334,439) | ||
Balance (in Shares) at Mar. 31, 2025 | [1] | 2,456,532 | ||||||
Net loss | [1] | (21,501,957) | (21,501,957) | |||||
Issuance of ordinary shares to underwriter | $ 65 | [1] | 1,540,960 | 1,541,025 | ||||
Issuance of ordinary shares to underwriter (in Shares) | [1] | 10,754 | ||||||
Warrant issued | [1] | 19,400,000 | 19,400,000 | |||||
Additional ordinary shares of round-up adjustment due to share consolidation | [1] | |||||||
Additional ordinary shares of round-up adjustment due to share consolidation (in Shares) | [1] | 51 | ||||||
Foreign currency translation | [1] | (147,962) | (147,962) | |||||
Balance at Jun. 30, 2025 | $ 14,804 | [1] | $ 29,743,558 | $ (48,567,032) | $ (234,663) | $ (19,043,333) | ||
Balance (in Shares) at Jun. 30, 2025 | [1] | 2,467,337 | ||||||
|
X | ||||||||||
- Definition The amount of sales of ordinary shares. No definition available.
|
X | ||||||||||
- Definition The number of sales of ordinary shares. No definition available.
|
X | ||||||||||
- Definition Additional ordinary shares of round-up adjustment due to share consolidation. No definition available.
|
X | ||||||||||
- Definition The number of shares for issuance of ordinary shares to underwriter. No definition available.
|
X | ||||||||||
- Definition Additional ordinary shares of round-up adjustment due to share consolidation. No definition available.
|
X | ||||||||||
- Definition The amount of issuance of ordinary shares to underwriter. No definition available.
|
X | ||||||||||
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|